• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向线粒体-炎症通路的 β-羟基丁酸可减轻 HFpEF。

Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.

机构信息

Laboratory of Mitochondrial and Metabolism, Department of Anesthesiology, National Clinical Research Center for Geriatrics (Y.D., M.X., Q.L., W.O., Y. Zhang, H.Y., Y. Zheng, Y.L., C.J., G.C., D.D., W.Z., S.W., M.G., T.L.), West China Hospital of Sichuan University, Chengdu.

Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center (Y.D., M.X., Q.L., W.O., Y. Zhang, H.Y., Y. Zheng, Y.L., C.J., G.C., T.L.), West China Hospital of Sichuan University, Chengdu.

出版信息

Circ Res. 2021 Jan 22;128(2):232-245. doi: 10.1161/CIRCRESAHA.120.317933. Epub 2020 Nov 12.

DOI:10.1161/CIRCRESAHA.120.317933
PMID:33176578
Abstract

RATIONALE

Over 50% of patients with heart failure have preserved ejection fraction (HFpEF), rather than reduced ejection fraction. Complexity of its pathophysiology and the lack of animal models hamper the development of effective therapy for HFpEF.

OBJECTIVE

This study was designed to investigate the metabolic mechanisms of HFpEF and test therapeutic interventions using a novel animal model.

METHODS AND RESULTS

By combining the age, long-term high-fat diet, and desoxycorticosterone pivalate challenge in a mouse model, we were able to recapture the myriad features of HFpEF. In these mice, mitochondrial hyperacetylation exacerbated while increasing ketone body availability rescued the phenotypes. The HFpEF mice exhibited overproduction of IL (interleukin)-1β/IL-18 and tissue fibrosis due to increased assembly of NLPR3 inflammasome on hyperacetylated mitochondria. Increasing β-hydroxybutyrate level attenuated NLPR3 inflammasome formation and antagonized proinflammatory cytokine-triggered mitochondrial dysfunction and fibrosis. Moreover, β-hydroxybutyrate downregulated the acetyl-CoA pool and mitochondrial acetylation, partially via activation of CS (citrate synthase) and inhibition of fatty acid uptake.

CONCLUSIONS

Therefore, we identify the interplay of mitochondrial hyperacetylation and inflammation as a key driver in HFpEF pathogenesis, which can be ameliorated by promoting β-hydroxybutyrate abundance.

摘要

背景

超过 50%的心衰患者射血分数保留(HFpEF),而非射血分数降低。其病理生理学的复杂性和缺乏动物模型阻碍了 HFpEF 有效治疗方法的发展。

目的

本研究旨在通过新型动物模型研究 HFpEF 的代谢机制并测试治疗干预措施。

方法和结果

通过在小鼠模型中结合年龄、长期高脂肪饮食和地塞米松棕榈酸酯挑战,我们能够重现 HFpEF 的多种特征。在这些小鼠中,线粒体过度乙酰化加剧,而增加酮体可用性则可挽救表型。HFpEF 小鼠由于过度组装 NLRP3 炎性体在过度乙酰化的线粒体上,导致 IL(白细胞介素)-1β/IL-18 过度产生和组织纤维化。增加 β-羟丁酸水平可减轻 NLRP3 炎性体的形成,并拮抗促炎细胞因子引发的线粒体功能障碍和纤维化。此外,β-羟丁酸可下调乙酰辅酶 A 池和线粒体乙酰化,部分通过激活 CS(柠檬酸合酶)和抑制脂肪酸摄取来实现。

结论

因此,我们确定线粒体过度乙酰化和炎症的相互作用是 HFpEF 发病机制的关键驱动因素,通过促进 β-羟丁酸丰度可改善该机制。

相似文献

1
Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.靶向线粒体-炎症通路的 β-羟基丁酸可减轻 HFpEF。
Circ Res. 2021 Jan 22;128(2):232-245. doi: 10.1161/CIRCRESAHA.120.317933. Epub 2020 Nov 12.
2
Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis During Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation.左西孟旦通过连接蛋白 43 信号激活逆转射血分数保留心力衰竭中心肌功能障碍和心肌细胞铁死亡。
Cardiovasc Drugs Ther. 2024 Aug;38(4):705-718. doi: 10.1007/s10557-023-07441-4. Epub 2023 Mar 7.
3
Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase.达格列净通过提升β-羟丁酸激活的柠檬酸合酶减轻射血分数保留心衰的心脏重构和功能障碍。
J Cardiovasc Pharmacol. 2023 Nov 1;82(5):375-388. doi: 10.1097/FJC.0000000000001474.
4
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.恩格列净通过减少促炎-氧化途径和蛋白激酶 Gα氧化改善射血分数保留的心力衰竭患者的内皮和心肌细胞功能。
Cardiovasc Res. 2021 Jan 21;117(2):495-507. doi: 10.1093/cvr/cvaa123.
5
Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.研究方案,随机对照试验:使用泛醇和/或D-核糖减轻射血分数保留的心力衰竭患者的症状负担
BMC Cardiovasc Disord. 2018 Apr 2;18(1):57. doi: 10.1186/s12872-018-0796-2.
6
NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction.MCC950 通过抑制 NLRP3 炎症小体减轻射血分数保留型心力衰竭中的心脏和肺动脉重构。
Life Sci. 2023 Nov 15;333:122185. doi: 10.1016/j.lfs.2023.122185. Epub 2023 Oct 17.
7
Knockout of MD1 contributes to sympathetic hyperactivity and exacerbates ventricular arrhythmias following heart failure with preserved ejection fraction via NLRP3 inflammasome activation.敲除 MD1 可导致射血分数保留型心力衰竭后交感神经活性亢进,并通过 NLRP3 炎性小体激活加重室性心律失常。
Exp Physiol. 2020 Jun;105(6):966-978. doi: 10.1113/EP088390. Epub 2020 May 6.
8
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.左室射血分数保留的心力衰竭中的线粒体功能障碍。
Circulation. 2019 Mar 12;139(11):1435-1450. doi: 10.1161/CIRCULATIONAHA.118.036259.
9
A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.一种新型 mtDNA 修复融合蛋白可减轻心力衰竭中的适应性重构并保护心功能。
Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H311-H321. doi: 10.1152/ajpheart.00515.2017. Epub 2017 Nov 3.
10
Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.胆碱通过 SIRT3-AMPK 通路调节代谢重编程和 UPRmt 来改善心肌肥厚。
Cardiovasc Res. 2019 Mar 1;115(3):530-545. doi: 10.1093/cvr/cvy217.

引用本文的文献

1
Clinically Meaningful Improvements in Long COVID Symptoms Following Ketogenic Metabolic Therapy Combined with Lifestyle Interventions-A Clinical Case Report and Review of the Literature.生酮代谢疗法联合生活方式干预后长期新冠症状的临床显著改善——一例临床病例报告及文献综述
Case Rep Clin Med. 2025 Aug;14(8):391-410. doi: 10.4236/crcm.2025.148052. Epub 2025 Aug 6.
2
Cardiomyocyte mitochondrial mono-ADP-ribosylation dictates cardiac tolerance to sepsis by configuring bioenergetic reserve in male mice.心肌细胞线粒体单磷酸腺苷核糖基化通过调节雄性小鼠的生物能量储备来决定心脏对脓毒症的耐受性。
Nat Commun. 2025 Aug 30;16(1):8119. doi: 10.1038/s41467-025-62384-8.
3
TGFBR1 gene silencing attenuates cardiomyopathy in the HFpEF mouse model.
TGFBR1基因沉默可减轻射血分数保留的心力衰竭小鼠模型中的心肌病。
PLoS One. 2025 Aug 29;20(8):e0328981. doi: 10.1371/journal.pone.0328981. eCollection 2025.
4
Novel Drug Targets in Diastolic Heart Disease.舒张性心脏病的新型药物靶点
Int J Mol Sci. 2025 Aug 20;26(16):8055. doi: 10.3390/ijms26168055.
5
Coronary microvascular disease in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的冠状动脉微血管疾病
Physiol Rep. 2025 Aug;13(16):e70521. doi: 10.14814/phy2.70521.
6
Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies.射血分数保留的心力衰竭与肥胖:新兴的代谢治疗策略
Diabetol Metab Syndr. 2025 Aug 18;17(1):336. doi: 10.1186/s13098-025-01917-z.
7
Aerobic Exercise Delays Age-Related Sarcopenia in Mice via Alleviating Imbalance in Mitochondrial Quality Control.有氧运动通过减轻线粒体质量控制失衡延缓小鼠与年龄相关的肌肉减少症。
Metabolites. 2025 Jul 11;15(7):472. doi: 10.3390/metabo15070472.
8
Ketone Bodies in Cardiovascular Disease: The Vasculature as a Therapeutic Target.心血管疾病中的酮体:以血管系统作为治疗靶点
JACC Basic Transl Sci. 2025 Jul 17;10(8):101328. doi: 10.1016/j.jacbts.2025.101328.
9
Cardiac substrate metabolism in type 2 diabetes.2型糖尿病中的心脏底物代谢
Biochem J. 2025 May 21;482(10):499-518. doi: 10.1042/BCJ20240189.
10
Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.心力衰竭中的心脏中间代谢:底物利用、信号作用及治疗靶点。
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01166-7.